Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Revenue (Quarterly): 8.52M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 8.52M |
| June 30, 2024 | 25.71M |
| March 31, 2024 | 13.01M |
| December 31, 2023 | 113.72M |
| September 30, 2023 | 16.92M |
| June 30, 2023 | 10.41M |
| March 31, 2023 | 12.67M |
| December 31, 2022 | 8.632M |
| September 30, 2022 | 25.15M |
| June 30, 2022 | 28.10M |
| March 31, 2022 | 5.897M |
| December 31, 2021 | 10.65M |
| September 30, 2021 | 8.517M |
| June 30, 2021 | 28.05M |
| March 31, 2021 | 14.66M |
| Date | Value |
|---|---|
| December 31, 2020 | 8.278M |
| September 30, 2020 | 17.82M |
| June 30, 2020 | 9.469M |
| March 31, 2020 | 7.152M |
| December 31, 2019 | 11.30M |
| September 30, 2019 | 12.28M |
| June 30, 2019 | 10.52M |
| March 31, 2019 | 8.629M |
| December 31, 2018 | 19.09M |
| September 30, 2018 | 7.836M |
| June 30, 2018 | 5.704M |
| March 31, 2018 | 5.793M |
| December 31, 2017 | 4.04M |
| September 30, 2017 | 17.50M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.897M
Minimum
Mar 2022
113.72M
Maximum
Dec 2023
19.23M
Average
11.99M
Median
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.79M |
| Total Expenses (Quarterly) | 76.44M |
| EPS Diluted (Quarterly) | -0.59 |
| Enterprise Value | -181.28M |
| Profit Margin (Quarterly) | -572.6% |
| Earnings Yield | -64.14% |
| Normalized Earnings Yield | -71.81 |